Applications of Biotechnology - Study Notes
Lesson summary
Biotechnology is the application of scientific and engineering principles to the processing of material by biological agents to provide goods and services. Recombinant DNA (rDNA) technology joins a gene from one organism to the DNA of another and has led to the large scale production of hormones, proteins and vaccines of therapeutic use. The term Biotechnology was coined in 1919 by the Hungarian agricultural engineer Karl Ereky.
9.1 Applications in medicine
Recombinant human insulin
- Made by the cells of the Islets of Langerhans; 51 amino acids in chain A (21) and chain B (30), joined by disulphide bonds.
- Deficiency causes diabetes mellitus. Earlier, insulin from pigs and cows caused allergic reactions in some patients.
- Best and Banting (1921) isolated insulin from the pancreatic islets of a dog.
- From the late 1970s the human insulin gene was inserted into plasmids of E.coli. The chains form pre-pro insulin; the leader sequence is removed and the C chain is excised.
- Insulin was the first pharmaceutical product of rDNA technology given to humans: approved 1982, marketed as Humulin in 1986.
- Rosie (1997), the first transgenic cow, gave milk with human alpha lactalbumin (2.4 g per litre).
Interferons
- Proteinaceous, antiviral, species specific substances made by mammalian cells infected with viruses; discovered by Alick Isaacs and Jean Lindemann in 1957; classified as alpha, beta and gamma.
- Produced in the yeast Saccharomyces cerevisiae because E.coli lacks the machinery for glycosylation of proteins.
- Used against cancer, AIDS, multiple sclerosis, hepatitis C and herpes zoster, but costly.
Recombinant vaccines
| Type | Feature |
|---|---|
| Subunit | Uses components (proteins, peptides, DNA) of a pathogen; pure, stable and safe. Example: hepatitis B vaccine cloned in Saccharomyces cerevisiae. |
| Attenuated | Genetically modified pathogens made nonpathogenic and used as live vaccines. |
| DNA vaccine | Came into being in 1990; a gene for an antigenic protein on a plasmid; cannot cause disease; cheap and easy to make. |
- Edible vaccines are made by molecular pharming in transgenic plants and are mucosal targeted; those for measles, cholera, foot and mouth disease and hepatitis are under development.
- The hepatitis B vaccine (HbsAg), launched in 1997 as Recombivax and Engerix-B, was the first synthetic vaccine. India was the fourth country after USA, France and Belgium to make it indigenously.
9.2 Gene therapy
- Transfer of a normal gene into the cells of a person with mutant alleles, using a vector.
- Gene augmentation therapy inserts DNA to replace a missing gene product; gene inhibition therapy inserts an anti sense gene to block a dominant gene.
- Somatic cell gene therapy (bone marrow, blood, skin cells) is not inherited; germ line gene therapy (eggs and sperms) is passed on.
- First clinical gene therapy: 1990, French Anderson, a four-year-old girl with ADA deficiency (SCID), an autosomal recessive disorder.
- Lymphocytes are cultured, given ADA cDNA through a retrovirus and returned. They are not immortal, so infusion is periodic. Putting the ADA gene into early embryonic cells could cure it permanently.
9.3 Stem cell therapy
- Stem cells are undifferentiated cells capable of self renewal and cellular potency.
- Embryonic stem cells come from the epiblast of the inner cell mass of a blastocyst, are immortal and can form more than 200 cell types.
- Adult stem cells are mostly multipotent and repair the body; the red bone marrow is a rich source.
| Potency | Meaning |
|---|---|
| Totipotency | One cell produces all differentiated cells of an organism |
| Pluripotency | Any of the three germ layers |
| Multipotency | Related cell types, e.g. blood stem cells to lymphocytes, monocytes, neutrophils |
| Oligopotency | Few cell types, e.g. lymphoid or myeloid cells to B and T cells but not RBC |
| Unipotency | Only one cell type |
- Stem cell banking: amniotic cell bank (amniotic fluid) and cord blood banking (umbilical cord at childbirth). Placenta, amniotic sac and amniotic fluid are also rich sources.
9.4 Molecular diagnostics
ELISA
- Discovered by Eva Engvall and Peter Perlmann (1971); detects antibodies or antigens in serum or urine; tells whether a person is HIV positive.
- The antigen is fixed on the plate, a specific antibody is added, and an anti-antibody linked to peroxidase reacts with hydrogen peroxide and 4-chloronaphthol to give a colour proportional to the antigen.
- Detects antigens in the nanogram range; four kinds: direct, indirect, sandwich and competitive; needs no radioisotopes.
PCR
- An in vitro amplification technique developed by Kary Mullis in 1983 (Nobel 1993).
- Steps: denaturation at 95 °C, annealing by rapid cooling, extension at 75 °C by Taq DNA polymerase from Thermus aquaticus.
- RT-PCR converts mRNA into cDNA with reverse transcriptase.
- Uses: diagnosis of sickle cell anaemia, beta-thalassemia, phenylketonuria, SARS-CoV-2 and cervical cancer caused by Papilloma virus; sexing of embryos; phylogenetics; DNA fingerprinting in forensic science; gene therapy.
9.5 Transgenic animals
- Transgenesis introduces foreign DNA (transgene) into an animal's genome for stable heritable characters.
- Steps: identify and separate the gene, select a vector (generally a virus), combine gene and vector, introduce the vector, demonstrate integration and expression.
- Examples: mice, rat, rabbit, pig, cow, goat, sheep and fish.
- Uses: models for cancer, Alzheimer's, cystic fibrosis, rheumatoid arthritis and sickle cell anaemia; transgenic mice test the safety of vaccines; toxicity testing; better milk, meat, eggs and wool.
9.6 Biological products
- Antitoxins, vaccines, blood products and hormone extracts; therapeutic proteins and monoclonal antibodies (for cancer, heart disease, transplant rejection).
- Animals serve as bioreactors. Natural protein adhesives can reattach tendons, fill tooth cavities and repair bones.
9.7 Animal cloning
- Dolly, the first cloned mammal, was made by Ian Wilmut and Campbell in 1997 by nuclear transfer and totipotency.
- Udder cells starved for 5 days became dormant and totipotent, were fused with enucleated ova, and the embryo grew in a surrogate ewe; Dolly was born five months later.
- Advantages: medical research, stem cell research, saving endangered species. Disadvantages: costly, animals suffer, high mortality, faster ageing, genetic disorders; more than 90% of attempts fail.
- A gene knock out carries genes made inoperative.
9.8 Ethical issues
Fears centre on genetic manipulation and unique microorganisms that could cause epidemics or be used in war, though the risks are slight and the benefits substantial.
More for this chapter
Book Back Questions9 textbook MCQs · solved
Additional MCQs24 extra MCQs · solved
Practice TestInteractive · instant score
Book Back TestTest yourself on the textbook set
Additional MCQ TestTest yourself on the extra set
Formula SheetAll key formulas